Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Quinidine is a Class Ia antiarrhythmic and antimalarial agent used to treat heart rhythm disorders and Plasmodium falciparum malaria. It works by blocking sodium and potassium channels to stabilize cardiac membranes.
Name
Quinidine
Raw Name
QUINIDINE GLUCONATE
Category
Other
Salt Form
Gluconate
Drug Count
5
Variant Count
9
Last Verified
February 17, 2026
RxCUI
852920, 1040054, 852877, 852913, 1040058
UNII
R6875N380F, 9D2RTI9KYH, J13S2394HE
About Quinidine
Quinidine is a Class Ia antiarrhythmic and antimalarial agent used to treat heart rhythm disorders and Plasmodium falciparum malaria. It works by blocking sodium and potassium channels to stabilize cardiac membranes.
Detailed information about Quinidine
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Quinidine.
Beyond its cardiac applications, Quinidine also possesses significant antimalarial properties, specifically targeting the erythrocytic (blood) stages of Plasmodium falciparum. While newer agents have largely supplanted it for routine use, Quinidine remains a critical therapeutic option for specific refractory (difficult to treat) arrhythmias and severe malaria cases. The FDA first approved Quinidine derivatives in the mid-20th century, and it remains a foundational drug in electrophysiology. It is important to note that Quinidine is an isomer of quinine, the traditional treatment for malaria, but Quinidine exerts a much more profound effect on cardiac tissue.
At the molecular level, Quinidine acts as a 'membrane stabilizer.' Its primary mechanism of action involves the inhibition of voltage-gated sodium channels (specifically the Nav1.5 channel in the heart). By binding to these channels during their open or inactivated states, Quinidine slows the 'Phase 0' depolarization of the cardiac action potential. This leads to a decrease in the maximal rate of rise (Vmax) of the action potential, which effectively slows down the speed at which electrical signals travel through the atria and ventricles.
Additionally, Quinidine is unique among Class I agents because it also blocks several types of potassium channels (such as the delayed rectifier current, IKr). By inhibiting potassium efflux, Quinidine prolongs the duration of the action potential and the effective refractory period (the time during which a heart cell cannot be stimulated to fire again). This dual action—slowing conduction and lengthening the 'reset' time—helps to suppress ectopic foci (abnormal electrical starting points) and break the 're-entry' circuits that cause conditions like atrial fibrillation or ventricular tachycardia.
Understanding how the body processes Quinidine is essential for safe administration, as it has a narrow therapeutic index (a small margin between a safe dose and a toxic dose).
Quinidine is FDA-approved for several specific cardiovascular and infectious indications:
Quinidine is available in several formulations to allow for both acute and chronic management:
> Important: Only your healthcare provider can determine if Quinidine is right for your specific condition. The choice between salt forms (gluconate vs. sulfate) is critical, as they contain different amounts of actual quinidine base.
Dosage of Quinidine must be highly individualized based on the patient's clinical response, heart rate, and blood levels of the drug.
Quinidine is rarely used in pediatric populations. When required, dosing is strictly weight-based (e.g., 30 mg/kg/day in 4 to 5 divided doses for the sulfate form). However, safety and efficacy in children have not been established through large-scale clinical trials. Most pediatric use is considered off-label and must be managed by a pediatric cardiologist or infectious disease specialist.
In patients with reduced kidney function, the excretion of Quinidine and its metabolites is slowed. Healthcare providers may reduce the frequency of dosing or the total daily dose to prevent accumulation. Close monitoring of serum quinidine levels is mandatory in patients with a GFR (Glomerular Filtration Rate) below 50 mL/min.
Since Quinidine is primarily metabolized by the liver, patients with cirrhosis or hepatitis are at a high risk of toxicity. Dose reductions of 25% to 50% are common, and frequent liver function tests (LFTs) are required during therapy.
Older adults often have decreased volume of distribution and slower clearance. They are also more susceptible to the side effect of orthostatic hypotension (dizziness upon standing). Providers typically 'start low and go slow' with this population.
To ensure the medication works effectively and to minimize side effects, follow these guidelines:
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose (within 4 hours), skip the missed dose and return to your regular schedule. Never double the dose to catch up, as this can lead to life-threatening cardiac toxicity.
An overdose of Quinidine is a medical emergency. Symptoms may include extreme dizziness, fainting, blurred vision, ringing in the ears (tinnitus), severe diarrhea, and a dangerously slow or irregular heartbeat. If an overdose is suspected, call 911 or your local emergency services immediately. In a hospital setting, treatment may include gastric lavage (stomach pumping), administration of sodium lactate to reverse cardiac effects, or cardiac pacing.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without direct medical guidance, as sudden discontinuation can cause your arrhythmia to return more severely.
Many patients taking Quinidine experience gastrointestinal issues, especially during the first few weeks of treatment. These include:
> Warning: Stop taking Quinidine and call your doctor or emergency services immediately if you experience any of the following:
Prolonged use of Quinidine requires ongoing vigilance. Long-term effects can include chronic changes in liver enzyme levels and the development of antinuclear antibodies (ANA), which may eventually lead to drug-induced lupus. Additionally, because Quinidine can affect the eyes, long-term users should have regular ophthalmic exams to check for changes in the retina or optic nerve.
Quinidine carries a significant FDA Black Box Warning regarding its use in non-life-threatening arrhythmias. Clinical trials (such as the CAST trial involving similar drugs) have shown that antiarrhythmic drugs can actually increase mortality (the risk of death) in patients with certain types of heart disease or non-critical arrhythmias. Because of this, Quinidine should only be used for documented, life-threatening arrhythmias or when the potential benefit clearly outweighs the risk of sudden cardiac death. It is not recommended for simple 'palpitations' or minor rhythm disturbances.
Report any unusual symptoms, no matter how minor they seem, to your healthcare provider immediately. Regular blood tests and EKGs are the best way to catch side effects before they become dangerous.
Quinidine is a high-alert medication that requires strict adherence to safety protocols. It has a narrow therapeutic window, meaning the difference between a dose that helps the heart and a dose that harms it is very small. Patients must be committed to regular follow-up appointments and laboratory monitoring.
WARNING: INCREASED MORTALITY. In many trials of antiarrhythmic therapy for non-life-threatening arrhythmias, these drugs (including Quinidine) have been associated with an increased risk of death compared to no treatment. Therefore, Quinidine should be reserved for patients with life-threatening ventricular arrhythmias or highly symptomatic atrial fibrillation where other treatments have failed. Your doctor will weigh this risk carefully before prescribing.
While taking Quinidine, you will need frequent testing:
Quinidine can cause dizziness, blurred vision, and lightheadedness. Do not drive, operate heavy machinery, or engage in hazardous activities until you know how this medication affects you. These effects are often worse during the first few days of treatment.
Avoid alcohol while taking Quinidine. Alcohol can increase the blood-pressure-lowering effects of Quinidine, leading to severe dizziness or fainting. Furthermore, chronic alcohol use can affect liver enzymes, making Quinidine levels unpredictable.
Never stop taking Quinidine abruptly unless instructed by your doctor due to a serious side effect. Sudden discontinuation can lead to a 'rebound' effect where your heart rhythm becomes highly unstable. If the drug needs to be stopped, your doctor will likely provide a tapering schedule.
> Important: Discuss all your medical conditions, especially any history of heart block, liver disease, or kidney disease, with your healthcare provider before starting Quinidine.
Certain drugs must NEVER be used with Quinidine due to the risk of fatal heart rhythms or extreme toxicity:
Quinidine can interfere with certain diagnostic tests, including urinary catecholamine tests (used to diagnose certain adrenal tumors) and some blood tests for liver function. Always inform lab personnel that you are taking Quinidine.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter antacids or cold medicines can interact with Quinidine.
Quinidine must NEVER be used in the following circumstances:
In these cases, the doctor will perform a careful risk-benefit analysis:
Patients who are allergic to Quinine (found in some leg cramp medications and tonic water) or Chloroquine are highly likely to be allergic to Quinidine. This 'cross-sensitivity' occurs because the chemical structures of these molecules are nearly identical. Always report any past reactions to antimalarial drugs to your cardiologist.
> Important: Your healthcare provider will evaluate your complete medical history, including an EKG and blood work, before deciding if Quinidine is a safe option for you.
Quinidine is classified as FDA Pregnancy Category C. This means that while there are no adequate, well-controlled studies in pregnant women, animal studies have shown potential risks, or the risks are simply unknown. Quinidine does cross the placenta and can reach the fetus. It has been used to treat fetal arrhythmias in specialized cases, but it can also cause uterine contractions. It should only be used during pregnancy if the potential benefit to the mother justifies the potential risk to the fetus. There is no evidence of specific birth defects (teratogenicity), but its use near term may cause neonatal thrombocytopenia.
Quinidine is excreted into breast milk. While the concentration in milk is generally lower than in the mother's blood, the infant's immature liver may not be able to process the drug effectively. A nursing infant could potentially develop cinchonism (tinnitus, vomiting). Most healthcare providers recommend either discontinuing breastfeeding or choosing an alternative medication if the mother must take Quinidine.
Quinidine is not FDA-approved for general use in children. Its use in pediatric patients is typically restricted to the treatment of severe malaria or rare, life-threatening arrhythmias managed by pediatric electrophysiologists. Because children have faster metabolic rates, they may require more frequent dosing, but they are also at higher risk for the gastrointestinal side effects that lead to dehydration.
Patients over the age of 65 are at a significantly higher risk for Quinidine toxicity. This is due to several factors:
In patients with kidney disease, the half-life of Quinidine metabolites is prolonged. While the parent drug is mostly metabolized by the liver, the kidneys are responsible for clearing the active metabolites. Patients with a creatinine clearance of less than 30 mL/min should receive significantly reduced doses, and serum level monitoring is mandatory.
Because the CYP3A4 system in the liver is the primary pathway for Quinidine clearance, liver disease (such as cirrhosis) can cause drug levels to skyrocket. Patients with hepatic impairment should be monitored daily for signs of cinchonism and should have their dose adjusted based on frequent serum level checks.
> Important: Special populations require individualized medical assessment and more frequent monitoring than the general population.
Quinidine is a Class Ia antiarrhythmic agent. Its primary molecular target is the Nav1.5 voltage-gated sodium channel. By binding to the alpha-subunit of this channel, Quinidine reduces the inward sodium current during Phase 0 of the cardiac action potential. This results in a slower rate of rise of the action potential (Vmax) and slower conduction velocity through the heart's specialized conduction system (His-Purkinje system).
Furthermore, Quinidine blocks several potassium channels, including the IKr (delayed rectifier) channel. This blockade slows down Phase 3 repolarization, which lengthens the total duration of the action potential and increases the effective refractory period (ERP). By making the heart cells 'unresponsive' for a longer period, Quinidine prevents rapid, disorganized electrical signals from triggering arrhythmias.
The clinical effect of Quinidine is directly related to its concentration in the blood. At therapeutic levels (2–6 mcg/mL), it stabilizes the heart rhythm. However, as levels rise, the 'use-dependent' block of sodium channels becomes more pronounced, which can lead to dangerously slow conduction (heart block). The effect on the QT interval is also dose-dependent; the more drug present, the longer the QT interval, and the higher the risk of Torsades de Pointes.
| Parameter | Value |
|---|---|
| Bioavailability | 70% - 80% |
| Protein Binding | 80% - 90% (Albumin & AAG) |
| Half-life | 6 - 8 hours |
| Tmax | 1 - 2 hours (Sulfate), 3 - 4 hours (Gluconate) |
| Metabolism | Hepatic (CYP3A4) |
| Excretion | Renal (20% unchanged), Fecal (minor) |
Quinidine is the prototype of the Class Ia antiarrhythmics. Related medications in this same sub-class include Procainamide and Disopyramide. While they all share the sodium-channel-blocking mechanism, Quinidine is unique for its significant alpha-adrenergic blocking activity, which can cause blood vessels to relax and blood pressure to drop.
Medications containing this ingredient
Common questions about Quinidine
Quinidine is primarily used to treat and prevent various types of irregular heartbeats, known as arrhythmias. Specifically, it is used to maintain a normal heart rhythm in patients with atrial fibrillation or atrial flutter after they have been stabilized. It is also indicated for the treatment of life-threatening ventricular arrhythmias, such as ventricular tachycardia. Beyond heart conditions, Quinidine is a vital treatment for severe malaria caused by the parasite Plasmodium falciparum. Because of its potential for serious side effects, it is usually reserved for cases where other medications have not worked or are not appropriate. Your doctor will determine the specific use based on your cardiac history and the severity of your condition.
The most frequent side effects of Quinidine are related to the digestive system, with diarrhea occurring in about 30% of patients. Other common issues include nausea, vomiting, and stomach pain, which can often be managed by taking the medication with food. Many patients also experience 'cinchonism,' a condition characterized by ringing in the ears (tinnitus), lightheadedness, and slightly blurred vision. While these common side effects are often manageable, they can sometimes be severe enough that the medication must be stopped. If you experience persistent diarrhea or hearing changes, you should contact your healthcare provider immediately. Regular monitoring helps ensure these side effects do not escalate into more serious health problems.
It is strongly advised that you avoid drinking alcohol while taking Quinidine. Alcohol can dilate your blood vessels, which may worsen the blood-pressure-lowering effects of Quinidine, leading to severe dizziness, lightheadedness, or even fainting. Additionally, chronic alcohol consumption can interfere with the liver enzymes (specifically CYP3A4) that break down Quinidine in your body. This interference can cause the levels of the drug in your blood to become dangerously high or too low to be effective. Combining alcohol with a heart rhythm medication also increases the overall stress on your cardiovascular system. Always consult your doctor before consuming any amount of alcohol while on this therapy.
Quinidine is generally not recommended during pregnancy unless the potential benefits to the mother significantly outweigh the risks to the unborn baby. It is classified as Pregnancy Category C, meaning there is insufficient data from human studies to guarantee its safety. While it has been used in some cases to treat heart rhythm problems in both the mother and the fetus, it is known to cross the placenta. There are also concerns that Quinidine could cause uterine contractions or lead to blood disorders in the newborn, such as low platelet counts. If you are pregnant or planning to become pregnant, you must have a detailed discussion with your cardiologist and obstetrician. They will likely explore safer alternatives before deciding on Quinidine.
The time it takes for Quinidine to work depends on the form you are taking and the condition being treated. For the immediate-release sulfate form, peak levels in the blood are usually reached within 1 to 2 hours. The extended-release gluconate form takes longer, typically reaching peak concentrations in 3 to 6 hours. When used for malaria via an intravenous infusion, the drug begins working almost immediately to target the parasites in the blood. For heart rhythm stabilization, it may take several days of consistent dosing to achieve a 'steady state' where the drug level is constant enough to prevent arrhythmias. Your doctor will use EKGs to monitor how quickly your heart is responding to the medication during this initial phase.
You should never stop taking Quinidine suddenly without your doctor's explicit instructions. Abruptly halting this medication can cause a 'rebound' effect, where your irregular heart rhythm returns, potentially more severely than before. This can lead to serious complications, including palpitations, shortness of breath, or even a stroke if atrial fibrillation recurs. If your doctor decides you should no longer take Quinidine, they will typically provide a schedule to gradually reduce your dose. This allows your heart's electrical system to adjust slowly. The only exception is if you experience a severe allergic reaction or a dangerous drop in platelets, in which case immediate discontinuation is necessary under medical supervision.
If you miss a dose of Quinidine, take it as soon as you remember to maintain consistent levels in your blood. However, if it is almost time for your next scheduled dose—specifically within 4 hours—you should skip the missed dose entirely. Do not take two doses at once to make up for the one you missed, as this can lead to toxic levels of the drug and dangerous heart rhythm changes. To help you remember, try using a pill organizer or a smartphone alarm. Consistency is vital for antiarrhythmic drugs to prevent 'gaps' in protection. If you miss more than one dose in a row, contact your healthcare provider for specific instructions on how to restart your regimen safely.
Weight gain is not a typical or common side effect of Quinidine. In fact, because Quinidine frequently causes gastrointestinal issues like diarrhea, nausea, and a loss of appetite, some patients may actually experience slight weight loss during the initial stages of treatment. If you notice rapid weight gain or swelling in your ankles and legs while taking Quinidine, this could be a sign of worsening heart failure rather than a direct side effect of the drug itself. Heart failure can cause the body to retain fluid, leading to a sudden increase in weight. You should report any significant or sudden changes in your weight to your doctor immediately for a cardiovascular evaluation.
Quinidine has many significant drug interactions, so it must be used with extreme caution alongside other medications. It is particularly known for doubling the levels of Digoxin in the blood, which can lead to Digoxin toxicity. It also interacts with blood thinners like Warfarin, increasing the risk of bleeding, and with many antidepressants and antipsychotics. Even over-the-counter medications like antacids or certain cold medicines can affect how Quinidine is absorbed or excreted. Because of these risks, it is essential to provide your doctor and pharmacist with a complete list of all prescriptions, supplements, and herbal products you take. They will monitor your blood levels and EKG closely whenever a new medication is added or removed.
Yes, Quinidine is available as a generic medication in both its sulfate and gluconate forms. Generic versions are required by the FDA to have the same active ingredient, strength, and effectiveness as the brand-name versions. Using the generic form can significantly reduce the cost of treatment for many patients. However, it is important to stay on the same generic manufacturer if possible, as small differences in the 'fillers' used in the tablets can sometimes affect how the drug is absorbed. You should check with your pharmacist to ensure you are receiving the correct salt form (gluconate vs. sulfate) prescribed by your doctor, as they are not interchangeable milligram-for-milligram.